Advertisement
Screener

Rocket One Inc. (RKTO) Accumulated Other Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

Rocket One Inc. Accumulated Other Comprehensive Income

Rocket One Inc. (RKTO) had Accumulated Other Comprehensive Income of $11.34 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14

  • 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $11.34K.
  • 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $12.41K.
  • 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $10.83K.
  • 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $11.03K.
Period endAccumulated Other Comprehensive Income (Loss), Net of Tax
2026-06-30$11.34K
10-Q · filed 2026-08-14
2026-03-31$12.41K
10-Q · filed 2026-05-15
2025-12-31$10.83K
10-Q · filed 2026-08-14
2025-09-30$11.03K
10-Q · filed 2025-11-12
2025-06-30$12.04K
10-Q · filed 2025-08-12
2025-03-31$8.57K
10-Q · filed 2025-05-12
2024-12-31$9.06K
10-K · filed 2026-03-27
2024-09-30$25.62K
10-Q · filed 2024-11-12
2024-06-30$23.13K
10-Q · filed 2024-08-09
2024-03-31$21.49K
10-Q · filed 2024-05-14
2023-12-31$27.26K
10-K · filed 2025-03-28
2023-09-30$22.75K
10-Q · filed 2023-11-13
2023-06-30-$23.71K
10-Q · filed 2023-08-11
2023-03-31$27.38K
10-Q · filed 2023-05-15
2022-12-31$22.01K
10-K · filed 2024-03-28
2022-09-30$49.57K
10-Q · filed 2022-11-10
2022-06-30$28.09K
10-Q · filed 2022-08-12
2022-03-31$13.86K
10-Q · filed 2022-05-12
2021-12-31$17.59K
10-K · filed 2023-03-31
2021-09-30$19.79K
10-Q · filed 2021-11-10
2021-06-30$186.00
10-Q · filed 2021-08-11
2021-03-31-$8.88K
10-Q · filed 2021-05-13
2020-12-31-$15.35K
10-K · filed 2022-03-30
2020-09-30-$3.49K
10-Q · filed 2020-11-10
2020-06-30-$662.00
10-Q · filed 2020-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Lipocine Inc. (LPCN)United States$0.017B-1.79
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52